Beyond the Hype: The Dangerous Truth You Weren’t Told About Semaglutide (And Why I Wrote The GLP-1 Nightmare)
We all saw the headlines. We watched the celebrity transformations. We listened to the stock market reports detailing the astronomical profits for the pharmaceutical giants manufacturing semaglutide and tirzepatide. For years, GLP-1 receptor agonists were sold to the public as the "miracle cure" for obesity—a simple injection that erased cravings and dissolved fat overnight.
But in the...